Shareholders Approve Massive Increase in Authorized Common Stock, Enabling Future Dilution
Summary
UNITED STATES ANTIMONY CORP shareholders approved an amendment to increase authorized common stock, enabling future capital raises but also significant potential dilution.
Key Events
-
Authorized Share Increase Approved
Shareholders approved an amendment to the Certificate of Formation to increase the number of shares authorized for issuance by the company. This follows a previous PRE 14A filing on April 10, 2026, which sought approval for a 'massive increase' in authorized common stock.
-
Directors Re-elected
All seven directors named in the Proxy Statement, including Gary C. Evans, Dr. Blaise Aguirre, and Lloyd Joseph Bardswich, were re-elected for a term of one year.
-
Auditor Ratified
The appointment of Sadler, Gibb & Associates, LLC as the independent registered public accounting firm for the fiscal year ending December 31, 2026, was ratified by shareholders.
Analysis
Shareholders have approved an amendment to significantly increase the number of authorized shares. This approval, following a prior proxy statement flagging a 'massive increase,' provides the company with the ability to issue a substantial amount of new equity. Given the company's reported Q1 net loss of $11.3 million and high cash burn, this authorization is critical for future capital raises but also signals a high potential for significant dilution for existing shareholders.
At the time of this filing, UAMY was trading at $7.51 on NYSE in the Manufacturing sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $1.94 to $19.71. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.